IRD · Opus Genetics, Inc. · Share Buybacks
Market Cap
$430.12M
Shares
83.20M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$50,000,000
as of 2023-08-10
· not restated in filings since 2024-05-10
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-01-13 | — | $40,000,000 | — | — | 10-Q , filed 2025-08-13 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2012-03-31 YTD | $0 | 10-Q, filed 2012-05-09 |
| 2011-12-31 | $0 | 10-K, filed 2012-03-16 |
| 2010-12-31 | $0 | 10-K, filed 2012-03-16 |
| 2009-12-31 | $0 | 10-K, filed 2012-03-16 |